logo
Plus   Neg
Share
Email

Evotec Lifts FY19 Adj. EBITDA Outlook

Evotec SE (EVTCY.PK,EVOTF.PK) said it raised adjusted Group EBITDA outlook for fiscal year 2019, primarily due to a strong operating performance in the fourth quarter of 2019 and high milestone revenues from long-term partnerships such as those with Celgene, Bayer and Sanofi in December 2019.

Looking ahead for the financial year 2019, the company now expects an increase of the adjusted Group EBITDA by more than 25% compared to 92.0 million euros reported in 2018. Earlier, the company had expected an increase of the adjusted Group EBITDA by about 15% in 2019.

The company confirmed all other elements of its financial guidance.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Global PC shipments returned to growth in the second quarter of 2020 after seeing a significant decline in the preceding first quarter due to COVID-19 related supply-chain disruptions, according to reports by two research firms. The PC market returned to growth in the quarter as production ramped up and vendors restocked their supplies to near-normal levels. The bankruptcy filing of America's oldest apparel retailer Brooks Brothers has ignited significant interest from potential buyers for the brand. WHP Global and a venture backed by Authentic Brands Group LLC and Simon Property Group, Inc., are reportedly considering bids for the retailer. WHP Global owns the ANNE KLEIN and JOSEPH ABBOUD brands. Sundial Herbal Products has recalled around 65 products, which were misbranded and currently unapproved drugs, the U.S. Food and Drug Administration said in a statement. The recall follows an order by a federal judge in June to stop distributing the company's unapproved new drugs. The affected items include herbal products and dietary supplements.
RELATED NEWS
Follow RTT